|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"chiu cf"
Showing items 46-70 of 115 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2016-07 |
Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL
|
Chang, TY;Chen, HA;Chiu, CF;Chang, YW;Kuo, TC;Tseng, PC;Wang, W;Hung, MC;Su, JL |
| 國家衛生研究院 |
2016-05 |
Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E;Von Hoff, DD;Chen, LT |
| 國家衛生研究院 |
2016-04-18 |
NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
|
Chiu, CF;Chang, YW;Kuo, KT;Shen, YS;Liu, CY;Yu, YH;Cheng, CC;Lee, KY;Chen, FC;Hsu, MK;Kuo, TC;Ma, JT;Su, JL |
| 國家衛生研究院 |
2016-02 |
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, G;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, RA;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, F;Moyo, V;Belanger, B;Dhindsa, N;Bayever, E;Von Hoff, DD;Chen, LT;the NAPOLI-1 Study Group. |
| 國家衛生研究院 |
2016-02 |
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Siveke, JT;Chen, LT;Von Hoff, DD;Li, CP;Wang-Gillam, A;Bodoky, G;Dean, A;Shan, YS;Jameson, G;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, RA;Chiu, CF;Schwartsmann, G;Braiteh, F;Moyo, V;Belanger, B;Bayever, E |
| 國家衛生研究院 |
2016-02 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy
|
Chiang, NJ;Yeh, KH;Chiu, CF;Chen, JS;Yen, CC;Lee, KD;Lin, YL;Bai, LY;Chen, MH;Lin, JS;Yang, Y;Rau, KM;Hsiao, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2016-02 |
Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E;Von Hoff, DD;Chen, LT |
| 國家衛生研究院 |
2015-07 |
CARMA3 represses metastasis suppressor NME2 to promote lung cancer stemness and metastasis
|
Chang, YW;Chiu, CF;Lee, KY;Hong, CC;Wang, YY;Cheng, CC;Jan, YH;Huang, MS;Hsiao, M;Ma, JT;Su, JL |
| 亞洲大學 |
2015-07 |
CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis
|
Chang, YW;Chang, YW;Chiu, CF;Chiu, CF;Lee, KY;Lee, KY;Hong, CC;Hong, CC;Wang, YY;Wang, YY;Cheng, CC;Cheng, CC;Jan, YH;Jan, YH;Huang, MS;Huang, MS;Hsiao, M;Hsiao, M;蘇振良 |
| 中國醫藥大學 |
2015-07 |
CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis
|
(Chang YW,);(Chiu CF);(Lee KY);(Hong CC);(Wang YY);(Cheng CC);(Jan YH);(Huang MS);(Hsiao M);(Ma JT);蘇振良(Jen-Liang Su)* |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-03 |
E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer
|
Chen, HA;Chang, YW;Tseng, CF;Chiu, CF;Hong, CC;Wang, W;Wang, MY;Hsiao, M;Ma, JT;Chen, CH;Jiang, SS;Wu, CH;Hung, MC;Huang, MT;Su, JL |
| 國家衛生研究院 |
2015-02 |
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma
|
Tsai, HJ;Lin, SF;Chen, CC;Chen, TY;Su, WC;Hwang, WL;Lin, JC;Chiou, TJ;Kao, WY;Chiu, CF;Chang, YF;Chang, JS;Chang, MC;Su, IJ |
| 國家衛生研究院 |
2015-01 |
Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Von Hoff, DD;Li, CP;Wang-Gillam, A;Bodoky, G;Dean, AP;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E |
| 國立交通大學 |
2014-12-08T15:27:38Z |
CMOS rotation-invariant pattern recognition system
|
Chiu, CF; Wu, CY |
| 國立交通大學 |
2014-12-08T15:03:14Z |
A NEW STRUCTURE OF THE 2-D SILICON RETINA
|
WU, CY; CHIU, CF |
| 國立交通大學 |
2014-12-08T15:01:54Z |
The design of rotation-invariant pattern recognition using the silicon retina
|
Chiu, CF; Wu, CY |
| 國家衛生研究院 |
2014-12 |
Suppression of dicer increases sensitivity to gefitinib in human lung cancer cells
|
Chen, JC;Su, YH;Chiu, CF;Chang, YW;Yu, YH;Tseng, CF;Chen, HA;Su, JL |
| 國家衛生研究院 |
2014-12 |
Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study
|
Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM |
| 國家衛生研究院 |
2014-12 |
Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-kappaB signaling in cervical cancer
|
Chang, YW;Chen, MW;Chiu, CF;Hong, CC;Cheng, CC;Hsiao, M;Chen, CA;Wei, LH;Su, JL |
| 國家衛生研究院 |
2014-12 |
Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma
|
Su, CM;Su, YH;Chiu, CF;Chang, YW;Hong, CC;Yu, YH;Ho, YS;Wu, CH;Yen, CS;Su, JL |
| 國家衛生研究院 |
2014-11 |
miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression
|
Hong, CC;Chen, PS;Chiou, J;Chiu, CF;Yang, CY;Hsiao, M;Chang, YW;Yu, YH;Hung, MC;Hsu, NW;Shiah, SG;Hsu, NY;Su, JL |
| 亞洲大學 |
2014-09 |
E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer
|
Chen, HA;Chen, HA;Chang, YW;Chang, YW;Tseng, CF;Tseng, CF;Chiu, CF;Chiu, CF;Hong, CC;Hong, CC;Wang, W;Wang, W;Wang, MY;Wang, MY;Hsiao, M;Hsiao, M;Ma JT, ;Chen CH, ;Jiang, SS;Jiang, SS;Wu, CH;Wu, CH;洪明奇;Huang, MT;Huang, MT |
| 亞洲大學 |
2014-09 |
miR-326 maturation is crucial for VEGF-C driven cortactin expression and esophageal cancer progression
|
Hong, CC;Hong, CC;Chen, PS;Chen, PS;Chiou, J;Chiou, J;Chiu, CF;Chiu, CF;Yang, CY;Yang, CY;Hsiao, M;Hsiao, M;Chang, YW;Chang, YW;Yu, YH;Yu, YH;Hung MC, ;Hsu NW, ;S;S;Hsu, NY;Hsu, NY;蘇振良* |
| 中國醫藥大學 |
2014-09 |
miR-326 maturation is crucial for VEGF-C driven cortactin expression and esophageal cancer progression
|
(Hong CC);(Chen PS);(Chiou J);(Chiu CF);(Yang CY);(Hsiao M);(Chang YW, , Hung MC);余養豪(Yang-Hao Yu);洪明奇(Mien-Chie Hung);(Hsu NW,);(Shiah SG);(Hsu NY);蘇振良(Jen-Liang Su)* |
Showing items 46-70 of 115 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
